0102030405
Tirzepatide CAS No. 2023788-19-2 Antidiabetic Pharmaceutical API
02
introduce
Tirzepatide is a potent GIP/GLP-1 dual receptor agonist and core therapeutic peptide API. It integrates dual incretin actions to lower blood glucose and reduce body weight, serving as a first-line treatment for type 2 diabetes.
Our products comply with strict international pharmaceutical standards to ensure high purity, stable efficacy and reliable supply.
02
Physical and chemical properties
Tirzepatide possesses key physical and chemical characteristics as follows:
- Solubility: Soluble in DMSO
- Stability: Stable under recommended storage conditions
- Storage Condition: Store at -20°C, sealed and protected from light; avoid repeated freeze-thaw cycles
- Solubility: Soluble in DMSO
- Stability: Stable under recommended storage conditions
- Storage Condition: Store at -20°C, sealed and protected from light; avoid repeated freeze-thaw cycles
Dual Targets Better Effect
As a dual agonist of GLP-1 and GIP receptors, it integrates the effects of two incretins. It can regulate metabolism more comprehensively, with more prominent hypoglycemic and weight-loss effects.
As a dual agonist of GLP-1 and GIP receptors, it integrates the effects of two incretins. It can regulate metabolism more comprehensively, with more prominent hypoglycemic and weight-loss effects.
Potent Clinical Efficacy
Compared with similar drugs (such as semaglutide), it has better hypoglycemic and weight-loss effects, which can reduce blood glucose levels and body weight more significantly.
Good Safety
Adverse reactions are similar to other incretin-based drugs, mostly mild to moderate gastrointestinal reactions, and no significant increase in hypoglycemia risk is found.
It is mainly used as a drug for metabolic-related diseases. The treatment mechanism is: as a dual agonist of GLP-1 and GIP receptors, it mimics the role of the body's own incretins, stimulates insulin secretion and reduces glucagon levels in a glucose-dependent manner, while delaying gastric emptying and inhibiting appetite, thereby achieving hypoglycemia and weight loss, and regulating glucose and lipid metabolism in the body. The specific applications include:
Treatment of Type 2 Diabetes: Combined with a reasonable diet and exercise program, it is used to control high blood sugar in patients with type 2 diabetes, reduce complications caused by high blood sugar such as kidney damage, blindness and neuropathy, and help patients lose weight at the same time.
We implement strict full-process quality inspection, with each batch of Tirzepatide undergoing rigorous testing on key indicators such as purity, solubility and impurity content to meet international pharmaceutical standards. Equipped with a stable raw material supply chain, we ensure continuous large-scale supply.
Our professional technical team provides tailored services including formulation optimization, application guidance and post-sales technical support for pharmaceutical enterprises and research institutions.
Our professional technical team provides tailored services including formulation optimization, application guidance and post-sales technical support for pharmaceutical enterprises and research institutions.
As a pioneering GIP/GLP-1 dual agonist, Tirzepatide has revolutionized the treatment of type 2 diabetes and obesity with its synergistic efficacy and convenient dosing. With stable product quality, proven clinical performance, broad application potential and reliable supply capacity, we are committed to providing high-quality Tirzepatide API and professional services for global customers.
Choose our Tirzepatide to meet your needs in pharmaceutical formulation, clinical treatment and biomedical research. Contact us for more product details and cooperation support.
Choose our Tirzepatide to meet your needs in pharmaceutical formulation, clinical treatment and biomedical research. Contact us for more product details and cooperation support.